ESR1 and neoplasm: This is supported by findings that xenograft models of PABC require systemic estrogen for their formation, and increasing the estrogen levels promotes the initiation and progression of ER-negative cancer (i.e., the tumor cells do not express estrogen receptors themselves) [29].